The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Acuderm sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Acuderm Inc (Acuderm) is a medical device company that develops and markets medical products, disposable instruments and dermatology supplies. Its product portfolio includes punches, curettes, acu-excisor, needles, syringes, sutures, smoke evacuation and electrosurgery products. It also offers lab supplies, gloves, cauteries, surgical instruments, dermatoscopes, cryosurgery and fungal culture media products. Acuderm’s needles include needle plastic hub, acu-needle plastic hub, exel needle plastic hub, liposuction needles and spinal needles. The company distributes its products across Australia, Canada, Denmark, France, Germany, Italy, Mexico, Portugal, Singapore, South Africa, South Korea, Spain. Acuderm is headquartered in Fort Lauderdale, Florida, the US.
The key metrics of Acuderm related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Acuderm is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Acuderm.
For a detailed understanding of the performance of Acuderm, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
